Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Rivian (RIVN) Stock Today: Recall News, AI Day Catalysts, and Fresh 2026–2030 Forecasts

Rivian (RIVN) Stock Today: Recall News, AI Day Catalysts, and Fresh 2026–2030 Forecasts

Rivian Automotive, Inc. heads into the last month of 2025 as one of the most hotly debated EV stocks on the market. On Friday, December 5, 2025, Rivian shares are trading around $18.16, near a one‑year high after a powerful rally driven by better‑than‑expected Q3 results, a deepening software partnership with Volkswagen, and rising excitement about the company’s upcoming “Autonomy & AI Day” on December 11. Stock Invest
Gulf Resources (GURE) Stock Soars After Regaining Nasdaq Compliance: Q3 2025 Shock Losses, Reverse Split and 2026 Outlook

Gulf Resources (GURE) Stock Soars After Regaining Nasdaq Compliance: Q3 2025 Shock Losses, Reverse Split and 2026 Outlook

Gulf Resources, Inc. Common Stock has suddenly jumped back onto traders’ radar in December 2025. The Chinese bromine and crude salt producer has regained compliance with Nasdaq’s listing requirements, executed a 1‑for‑10 reverse stock split, and seen its share price explode in early December trading — all against a backdrop of huge accounting losses and a formal going‑concern warning from management. Nasdaq+2NASDAQ Trader+2
5 December 2025
Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines, Inc. extended its remarkable 2025 rally on Friday, December 5, with shares surging almost 40% intraday after the company reported a double dose of good news: a pivotal epilepsy trial stopped early for efficacy and a positive pre-NDA meeting with the U.S. Food and Drug Administration for its lead essential tremor drug. StockAnalysis+3TradingView+3Stock Titan+3
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics, Inc. has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its lead drug program and launched a strategic review.
Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp’s Nasdaq-listed shares are back in the spotlight after a dramatic late‑week move. On Thursday evening, the micro‑cap stock surged about 45% in after‑hours trading to roughly $1.37, after the company disclosed that shareholders had approved sweeping capital‑structure changes linked to its reverse merger with First Towers & Fiber Corp and a package of convertible debt. Benzinga+2Stock Titan+2
SEALSQ Corp (LAES) Stock: Quantum-Security High‑Flier After EeroQ Deal – Outlook as of December 5, 2025

SEALSQ Corp (LAES) Stock: Quantum-Security High‑Flier After EeroQ Deal – Outlook as of December 5, 2025

As of December 5, 2025, SEALSQ Corp sits at the intersection of three crowded buzzwords—semiconductors, cybersecurity and quantum computing—and its stock has traded accordingly: violently. Shares are hovering in the mid‑$5 range after an 8%+ jump on December 4, capping a roughly 1,000% gain over the past year and a double‑digit rally over the last week.StockInvest+1 At the same time, the company remains unprofitable and richly valued, which makes SEALSQ one of the more speculative post‑quantum security plays in the market.
5 December 2025
Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

As of December 5, 2025, Samsara Inc. has just delivered a landmark quarter: its first ever GAAP profit, another round of 29% top-line growth, and a fresh batch of Wall Street price targets clustered around $50 per share. Yet the stock is still trading in the low $40s and remains well below its 2025 peak, leaving investors debating whether IOT is a high‑growth bargain or a richly priced momentum story.
1 548 549 550 551 552 608

Stock Market Today

  • LVS, NRG, DUOL display significant options volumes Monday
    July 27, 2026, 4:03 PM EDT. Las Vegas Sands Corp (LVS) recorded elevated options volume Monday, with 35,829 contracts (~3.6 million shares) focused on the $50 strike call set to expire Sept 18, 2026. NRG Energy Inc (NRG) posted 15,810 contracts (~1.6 million shares), largely targeting the $190 strike call with the same expiration. Duolingo Inc (DUOL) options reached 6,362 contracts (~636,200 shares), concentrated in the $150 strike call maturing July 31, 2026. In each case, trades exceeded 60% of the typical daily volume for these companies.